Search clinical trials for: Rifamycin SV-MMX® Placebo

Total 2659 results

Dr. Falk Pharma GmbH

Completed

Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis

Uncomplicated Diverticulitis

Germany
RedHill Biopharma Limited

Not yet recruiting

Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years

Traveler's Diarrhea
RedHill Biopharma Limited

Not yet recruiting

Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years

Traveler's Diarrhea
Cosmo Technologies Ltd

Completed

Pharmacokinetics and Safety Study of Rifamycin SV-MMX® 600 mg Tablets After Single and Multiple t.i.d. Doses in Healthy Male and Female Volunteers

Healthy
Cosmo Technologies Ltd
Bausch Health Americas, Inc.

Completed

Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)

Traveler's Diarrhea

Guatemala, Mexico
Hunter Holmes Mcguire Veteran Affairs Medical Center

Completed

Rifamycin in Minimal Hepatic Encephalopathy (RIVET)

Hepatic Encephalopathy | Cirrhosis, Liver

United States
Bradley Connor

Enrolling by invitation

Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

Gastrointestinal Disease | Small Intestinal Bacterial Overgrowth | Gastrointestinal Infection

United States
Cosmo Technologies Ltd

Completed

Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D

Diarrhea-predominant Irritable Bowel Syndrome

Belgium, Germany, Italy, Spain
Cosmo Technologies Ltd

Completed

Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea

Infectious Diarrhoea
Centre Hospitalier Universitaire, Amiens

Completed

Prevalence of Conjunctivitis and Indentification of Risk Factors With and Without Prophylactic Antibiotic Treatment in Neonates (CRY-NOT)

Ophthalmia Neonatorum

France
Dr. Falk Pharma GmbH

Completed

Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea (ERASE)

Traveler's Diarrhea

Ecuador, Guatemala, India
National Taiwan University Hospital

Recruiting

The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study

Pulmonology

Taiwan
Yuzuncu Yıl University

Active, not recruiting

Evaluation of the Effects of Irrigation of the Extraction Socket With Rifamycine

Impacted Third Molar Tooth

Turkey
Capso Vision, Inc.

Unknown

Study for the Detection of Duodenal Papilla Using Capsule Endoscopy and Comparison of Images With EUS/ERCP Procedure.

Patients Indicated for Periampullary or Pancreaticobiliary Examination

United States
University of Southern California

Completed

Lavender Aromatherapy for Anxiety During Urodynamics

Pain | Anxiety

United States
Kyoto University, Graduate School of Medicine
Philips Healthcare; Philips Respironics

Completed

The Effect of Adaptive Servo Ventilation and Oxygen Therapy in Central Sleep Apnea Patients

Sleep Apnea | Chronic Heart Failure

Japan
Cosmo Technologies Ltd

Completed

The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

Colorectal Cancer

United States, Belgium, Canada, Germany, Italy, Lithuania, Netherlands, United Kingdom
University of Washington
Fred Hutchinson Cancer Center; National Institute of General Medical Sciences...

Completed

Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions

Adverse Drug Interactions

United States
University Hospital, Toulouse

Not yet recruiting

Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients (NORAFLOW)

Hypotension

France
Bausch Health Americas, Inc.
Cosmo Technologies Ltd

Completed

(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Ulcerative Colitis

Russian Federation, United Kingdom, Latvia, Poland, Estonia, Belgium, Australia, Lithuania, France, Sweden, Israel, Italy, Romania, Slovakia, Ukraine
University of Sao Paulo General Hospital
GlaxoSmithKline

Recruiting

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases (RZVRheum)

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Systemic Sclerosis | Juvenile Idiopathic Arthritis | Sjogren's Syndrome | Spondylitis, Ankylosing | Spondyloarthritis | Behçet Disease | Idiopathic Inflammatory Myopathies | Vasculitis, Systemic | Dermatomyositis, Juvenile

Brazil
Windtree Therapeutics

Completed

Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old (KL4-AHRF-01)

Acute Hypoxemic Respiratory Failure

United States, Chile
Medical College of Wisconsin
SPIO

Recruiting

Orthosis to Improve Trunk Control in Infants Age 6-18 Months

Cerebral Palsy

United States
Bausch Health Americas, Inc.

Completed

(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Ulcerative Colitis

United States, Canada, India, Mexico
Joint Stock Company "Farmak"

Completed

A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus

Covid-19 Disease

Ukraine
Ascensia Diabetes Care

Completed

Evaluation of Blood Glucose Monitoring Systems

Diabetes

United States
Chugai Pharmaceutical

Completed

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Medical University of Vienna

Completed

Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects

Intraocular Pressure | Ocular Physiology | Regional Blood Flow

Austria
GlaxoSmithKline

Completed

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Measles | Rubella | Mumps | Varicella

Germany, Austria
Ain Shams University

Not yet recruiting

Healing Potentiality of Trypsin and Alpha Chemo Trypsin in Mandibular Molars With Chronic Apical Abscess

Mandibular Abscess

Egypt
Novo Nordisk A/S

Completed

Comparison of NovoFine® Needles (4 mm vs. 6 mm)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Denmark
CymaBay Therapeutics, Inc.

Completed

Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
McMaster University

Unknown

Homeopathic Vaccine Trial (HVT)

Healthy Volunteers

Canada
3-D Matrix Europe SAS

Completed

IEIK13 For Neurosurgery

Oozing (Hemorrhage) During Intracranial Procedures

Belgium
Hospital Universitario Central de Asturias
Johnson & Johnson

Unknown

Evaluation of Thermocool SF Catheter on the Common Cavo-tricuspid Isthmus Dependent Atrial Flutter Ablation

Atrial Flutter.

Spain
Sidney Kimmel Comprehensive Cancer Center at Johns...
Greater Washington Community Foundation

Terminated

Muscadine Plus (MPX) In Men With Prostate Cancer

Adenocarcinoma of the Prostate

United States
University Hospital, Gentofte, Copenhagen
B. Braun Melsungen AG

Completed

Choice of Material for Above-Knee Femoro-Popliteal Bypass Prosthetic Graft (PopUp)

Intermittent Claudication | Critical Limb Ischemia
Shire

Completed

Amoxicillin Drug Interaction Study With MMX® Mesalazine/Mesalamine

Healthy

United States
Novartis Pharmaceuticals

Terminated

A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms

Renal Transplantation

United States
Yonsei University
Small and Medium Business Administration

Completed

The Efficacy and Safety of Accufuser Omnibus® (Elastomeric Infusion Pump); Comparative Clinical Trial

Upper Gastrointestinal Cancer

Korea, Republic of
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders in Patients With Ischemic Stroke in the Carotid Arteries

Cognitive Disorders

Russian Federation
Teijin America, Inc.

Completed

Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

Diabetic Kidney Disease

United States
BioMimetix JV, LLC

Completed

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

Psoriasis | Atopic Dermatitis

United States
4D pharma plc

Withdrawn

A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19

COVID-19

United Kingdom
Celsus Therapeutics PLC

Terminated

Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% (C012013)

Atopic Dermatitis

Israel
Mozart Therapeutics Australia Pty Ltd

Not yet recruiting

Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients

Type 1 Diabetes | Celiac Disease | Healthy Volunteers

Australia
Maxinovel Pty., Ltd.

Not yet recruiting

A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects

Alopecia Areata
BioMimetix JV, LLC
Innovaderm Research Inc.

Terminated

A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis

Atopic Dermatitis

United States
4D pharma plc

Terminated

A Study of MRx-4DP0004 in Asthma

Asthma

United States, United Kingdom
Moerae Matrix, Inc.

Unknown

Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide (LPS)

Acute Inflammatory Response to Non-antigenic Stimulus

United Kingdom

Search clinical trials for: Rifamycin SV-MMX® Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations